PL373400A1 - Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) - Google Patents

Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr)

Info

Publication number
PL373400A1
PL373400A1 PL02373400A PL37340002A PL373400A1 PL 373400 A1 PL373400 A1 PL 373400A1 PL 02373400 A PL02373400 A PL 02373400A PL 37340002 A PL37340002 A PL 37340002A PL 373400 A1 PL373400 A1 PL 373400A1
Authority
PL
Poland
Prior art keywords
gpcr
ligands
protein coupled
coupled receptors
tetrahydrocarbozole
Prior art date
Application number
PL02373400A
Other languages
Polish (pl)
Inventor
Marcus Koppitz
Hans Peter Muhn
Ken Shaw
Holger Hess-Stumpp
Klaus Paulini
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10164564A external-priority patent/DE10164564B4/en
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of PL373400A1 publication Critical patent/PL373400A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02373400A 2001-12-14 2002-12-16 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) PL373400A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10164564A DE10164564B4 (en) 2001-12-14 2001-12-14 Tetrahydrocarbazole derivatives as ligands for G-protein coupled receptors (GPCR)
US34187801P 2001-12-21 2001-12-21

Publications (1)

Publication Number Publication Date
PL373400A1 true PL373400A1 (en) 2005-08-22

Family

ID=26010882

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02373400A PL373400A1 (en) 2001-12-14 2002-12-16 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr)

Country Status (17)

Country Link
EP (1) EP1453803A2 (en)
JP (1) JP2005518375A (en)
CN (1) CN100500654C (en)
AR (1) AR037863A1 (en)
AU (1) AU2002361430B2 (en)
BR (1) BR0214958A (en)
CA (1) CA2468880A1 (en)
HR (1) HRP20040609A2 (en)
HU (1) HUP0500014A3 (en)
IL (2) IL161626A0 (en)
MX (1) MXPA04005768A (en)
NO (1) NO326692B1 (en)
NZ (1) NZ533430A (en)
PL (1) PL373400A1 (en)
RU (1) RU2319692C2 (en)
TW (1) TWI246423B (en)
WO (1) WO2003051837A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1638551T1 (en) * 2003-05-19 2012-04-30 Irm Llc Immunosuppressant compounds and compositions
ES2314446T3 (en) * 2003-06-10 2009-03-16 Smithkline Beecham Corporation DERIVATIVES OF TETRAHYDROCARBAZOL AND ITS PHARMACEUTICAL USE.
US20060074124A1 (en) 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
US20050209300A1 (en) * 2003-09-12 2005-09-22 Andrew Napper Methods of treating a disorder
DE102004033902A1 (en) 2004-07-14 2006-02-16 Zentaris Gmbh New tetrahydrocarbazole compounds are neurokinin-1 receptor antagonists useful to treat or prevent e.g. pubertas praecox, hirsutism, polycystic ovary syndrome, hormone dependent neoplastic diseases and Alzheimer's disease
PT1833791E (en) * 2004-12-27 2011-10-19 Actelion Pharmaceuticals Ltd 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
BRPI0611705A2 (en) * 2005-06-24 2016-11-16 Lilly Co Eli compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of compound
KR101411820B1 (en) * 2006-08-07 2014-06-24 액테리온 파마슈티칼 리미티드 (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
EP1967202A1 (en) * 2007-03-05 2008-09-10 AEterna Zentaris GmbH Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity
EP1988098A1 (en) * 2007-04-27 2008-11-05 AEterna Zentaris GmbH Novel Tetrahydrocarbazole Derivatives as Ligands of G-protein Coupled Receptors
EP2095818A1 (en) 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
BR112012024114B1 (en) 2010-03-22 2021-02-09 Idorsia Pharmaceuticals Ltd COMPOUNDS DERIVED FROM 3- (HETEROARYLAMINE) -1,2,3,4-TETRAHYDRO-9H-CARBAZOLE, USE OF THE SAME, AND, PHARMACEUTICAL COMPOSITION
CN103459389B (en) 2011-04-14 2016-03-30 埃科特莱茵药品有限公司 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyridine is [1,2-a] ethychlozate derivative and its purposes as prostaglandin D 2 receptor conditioning agent also
PE20161177A1 (en) 2014-03-17 2016-11-18 Actelion Pharmaceuticals Ltd DERIVATIVES OF AZAINDOL ACETIC ACID AND THEIR USE AS MODULATORS OF THE PROSTAGLANDIN D2 RECEPTOR
US9850241B2 (en) 2014-03-18 2017-12-26 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
TWI711616B (en) 2015-09-15 2020-12-01 瑞士商愛杜西亞製藥有限公司 Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1418703A (en) * 1973-06-02 1975-12-24 Pfizer Ltd 3-alkyl-9-substituted-1,2,3,4-tetrahydrocarbazoles
EP0239306B1 (en) * 1986-03-27 1993-06-02 Merck Frosst Canada Inc. Tetrahydrocarbazole esters
US5607939A (en) * 1994-04-28 1997-03-04 Takeda Chemical Industries, Ltd. Condensed heterocyclic compounds, their production and use
EP0986385A4 (en) * 1997-06-05 2001-05-16 Merck & Co Inc Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
JP2005518375A (en) 2005-06-23
CA2468880A1 (en) 2003-06-26
RU2004121776A (en) 2005-05-10
WO2003051837A2 (en) 2003-06-26
AU2002361430B2 (en) 2007-09-13
IL161626A0 (en) 2004-09-27
CN1599720A (en) 2005-03-23
MXPA04005768A (en) 2004-09-10
HUP0500014A2 (en) 2005-04-28
RU2319692C2 (en) 2008-03-20
AR037863A1 (en) 2004-12-09
TW200305405A (en) 2003-11-01
WO2003051837A8 (en) 2004-05-06
NO20042198L (en) 2004-07-09
WO2003051837A3 (en) 2004-02-26
AU2002361430A1 (en) 2003-06-30
BR0214958A (en) 2004-12-28
HRP20040609A2 (en) 2005-06-30
CN100500654C (en) 2009-06-17
NZ533430A (en) 2005-12-23
EP1453803A2 (en) 2004-09-08
NO326692B1 (en) 2009-02-02
TWI246423B (en) 2006-01-01
HUP0500014A3 (en) 2010-06-28
IL192991A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
IL161626A0 (en) Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr)
AU2001268471A1 (en) G-protein coupled receptors
AU2003227909A1 (en) Imidazo-triazine derivatives as ligands for gaba receptors
AU1956701A (en) G-protein coupled receptors
PL373953A1 (en) 7-amino-benzothiazole derivatives as adenosine receptor ligands
AU2002215100A1 (en) Imidazo-pyrimidine derivatives as ligands for gaba receptors
AU2001234766A1 (en) G-protein coupled receptors
AU2001280785A1 (en) G-protein coupled receptors
AU2001264721A1 (en) G-protein coupled receptors
AU4439801A (en) Pyrazolo-triazine derivatives as ligands for gaba receptors
DE10164564B4 (en) Tetrahydrocarbazole derivatives as ligands for G-protein coupled receptors (GPCR)
AU2001270822A1 (en) Imidazolophthalazine derivatives as ligands for gabaa receptors
AU2001240097A1 (en) G protein-coupled receptors
AU2001251175A1 (en) G-protein coupled receptors
AU2001261814A1 (en) G-protein coupled receptors
AU2001296444A1 (en) G-protein coupled receptors
GB0226227D0 (en) Receptors
AU2001240019A1 (en) G-protein coupled receptors
AU2001249922A1 (en) G protein-coupled receptors
EP1442117A4 (en) Gastrointestinal chemosensory receptors
AU2002235543A1 (en) Imidazolophthalazine derivatives as ligands for gabaa receptors
AU2002327615A1 (en) G-protein coupled receptors
AU2002254466A1 (en) G-protein coupled receptors
AU2001259322A1 (en) G protein-coupled receptors
AU2002316366A1 (en) G-protein coupled receptors

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)